Biodesix, Inc.
BDSX
$8.44
$0.303.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.74% | 11.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.74% | 11.47% | |||
| Cost of Revenue | 1.86% | 8.86% | |||
| Gross Profit | 10.48% | 12.15% | |||
| SG&A Expenses | -3.11% | 9.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.03% | 9.96% | |||
| Operating Income | 27.33% | -6.95% | |||
| Income Before Tax | 24.00% | -3.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.00% | -3.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.00% | -3.31% | |||
| EBIT | 27.33% | -6.95% | |||
| EBITDA | 31.73% | -8.32% | |||
| EPS Basic | 25.69% | -3.23% | |||
| Normalized Basic EPS | 25.57% | -3.67% | |||
| EPS Diluted | 25.69% | -3.23% | |||
| Normalized Diluted EPS | 25.57% | -3.67% | |||
| Average Basic Shares Outstanding | 2.28% | 0.07% | |||
| Average Diluted Shares Outstanding | 2.28% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||